GlassScriptPhysician profile
Jack P Mourad
NPI 1912972050
$4,462.37
in general payments reported to CMS, 2019-2025
24 companies · $597 in 2025
The $597 reported for 2025 was less than what a typical Rheumatology provider received nationally (typical 2025 total: $894).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,339 · 2020: $245 · 2021: $302 · 2022: $619 · 2023: $716 · 2024: $645 · 2025: $597.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,957.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,957.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $905.08 | 2019-2025 | |
| Mallinckrodt Hospital Products INC. | $672.28 | 2020-2025 | Acthar |
| Ani Pharmaceuticals, INC. | $376.38 | 2023-2025 | Purified Cortrophin Gel |
| Ucb, INC. | $296.80 | 2019-2024 | Cimzia, Bimzelx |
| Pfizer INC. | $280.29 | 2019-2024 | |
| Collegium Pharmaceutical, INC. | $222.51 | 2019-2025 | Xtampza |
| Glaxosmithkline, LLC. | $220.80 | 2019-2023 | Benlysta, Nucala |
| Biodelivery Sciences International, INC. | $220.32 | 2019-2021 | |
| Amgen INC. | $217.91 | 2019-2025 | Prolia, Tavneos, Evenity |
| Astrazeneca Pharmaceuticals LP | $191.05 | 2019-2022 | |
| Horizon Therapeutics Plc | $136.51 | 2019 | |
| Lilly USA, LLC | $119.19 | 2019-2024 | Taltz |
| E.R. Squibb & Sons, L.L.C. | $99.21 | 2019-2021 | |
| Regeneron Healthcare Solutions, INC. | $92.21 | 2019 | |
| Mdd US Operations, LLC | $84.57 | 2019 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $78.87 | 2019-2021 | |
| Teva Pharmaceuticals USA, INC. | $64.33 | 2019 | |
| Mallinckrodt Enterprises LLC | $53.59 | 2019 | |
| Novo Nordisk INC | $33.19 | 2022 | |
| Exact Sciences Corporation | $22.54 | 2023 | Cologuard Collection Kit |
| Medexus Pharma, INC. | $21.04 | 2019 | |
| Kaleo, INC. | $19.44 | 2019 | |
| Amarin Pharma, INC. | $18.89 | 2022 | |
| Allergan, INC. | $15.37 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jack Mourad listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.